North America & Europe Artificial Pancreas Systems Market, By Disease Type (Diabetes Type 1, Diabetes Type 2), By End User (Hospitals, Clinics), By Region (North America, Europe) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

North America & Europe Artificial Pancreas Systems Market, By Disease Type (Diabetes Type 1, Diabetes Type 2), By End User (Hospitals, Clinics), By Region (North America, Europe) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

An artificial pancreas is a man-made device which replicates the functions of a pancreas. It is capable of releasing insulin in response to the changing levels of blood glucose in the body similar to natural pancreas. Types of artificial pancreas include closed-loop artificial pancreas, bionic pancreas, and implanted artificial pancreas. Companies such as Beta Bionics, Bigfoot Biomedical, Medtronic, Insulet, and others are present in the artificial pancreas market. Moreover, Approvals, launches and frequent partnerships among key players for development of novel artificial pancreas is expected to drive the global artificial pancreas device system (APDS) market growth over the forecast period. For instance, In July 2021, Beta Bionics, Inc., announced the U.S. FDA approval of a supplement filed by Beta Bionics to its previously approved investigational device exemption (IDE), expanding ongoing home-use clinical trials testing its new integrated technology, which combines the iLet bionic pancreas and the Senseonics Eversense CGM. With this approval, Beta Bionics, Inc. began clinical testing of Eversense-compatible iLet comes less than three weeks after Senseonics received the U.S. FDA approval to begin commercial marketing of Eversense for adults with diabetes.
Restraints of the North America & Europe Artificial Pancreas Systems Market
Restraining factors such as high costs, and possibility of inappropriate dosing of insulin are expected to restrain North America & Europe artificial pancreas systems market growth over the forecast period.
Key features of the study:
This report provides in-depth analysis of the North America & Europe artificial pancreas systems market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the North America & Europe artificial pancreas systems market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Medtronic Plc., Johnson and Johnson Services Inc., Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., and Cellnovo
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The North America & Europe artificial pancreas systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
North America & Europe Artificial Pancreas Systems Market, By Disease Type:
Diabetes Type 1
Diabetes Type 2
North America & Europe Artificial Pancreas Systems Market, By End User:
Hospitals
Clinics
North America & Europe Artificial Pancreas Systems Market, By Region:
North America
By Disease Type
Diabetes Type 1
Diabetes Type 2
By End User:
Hospitals
Clinics
By Country:
U.S.
Canada
Europe
By Disease Type
Diabetes Type 1
Diabetes Type 2
By End User:
Hospitals
Clinics
By Country:
U.K.
France
Germany
Spain
Italy
Russia
Rest of Europe
Company Profiles
Medtronic Plc*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Johnson and Johnson Services Inc.
Dexcom Inc.
Insulet Corporation
Tandem Diabetes Care Inc.
Cellnovo
“*” marked represents similar segmentation in other categories in the respective section.